Recent Quotes (30 days)

You have no recent quotes
chg | %

GeneNews Ltd  

(Public, TSE:GEN)   Watch this stock  
Find more results for GEN
0.0000 (0.00%)
Oct 18 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.09 - 0.09
52 week 0.08 - 0.53
Open 0.09
Vol / Avg. 78,000.00/196,501.00
Mkt cap 8.68M
P/E     -
Div/yield     -
EPS -0.07
Shares 96.48M
Beta 10.75
Inst. own     -
Nov 9, 2017
Q3 2017 GeneNews Ltd Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 15, 2017
Q2 2017 GeneNews Ltd Earnings Release
Aug 15, 2017
Q2 2017 GeneNews Ltd Earnings Call

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -402.46% -560.76%
Operating margin -1400.92% -552.01%
EBITD margin - -419.80%
Return on average assets -58.90% -294.52%
Return on average equity - -
Employees 4 -
CDP Score - -


445 Apple Creek Blvd Unit 220
+1-905-7392030 (Phone)
+1-905-7392031 (Fax)

Website links


GeneNews Limited is focused on developing and commercializing molecular diagnostic tests for early detection of diseases and for personalized health management, with a primary focus on cancer-related indications. The Company offers Sentinel Principle, which is a platform technology to detect virtually any disease or medical condition from a simple blood sample. The Company also offers ColonSentry, which is a blood-based test for assessing an individual's current risk of having colorectal cancer. The Company operates within the biotechnology, molecular diagnostic and genomic biomarker industry. The Company operates in Canada and the United States, and transacts business primarily with the United States partners and suppliers. The Company's subsidiaries include GeneNews Corporation and GeneNews Inc.

Officers and directors

James R. Howard-Tripp Executive Chairman of the Board
Leslie Auld Chief Financial Officer, Treasurer, Director
Karl Wassmann Executive Vice President - US Corporate Development
Heinrich Dreismann Ph.D. Lead Director
Age: 63
Harry A. Glorikian Independent Director
Age: 50
Garth A. C. MacRae Independent Director
Age: 82
Rory B. Riggs Independent Director
Age: 64